2-(4-氯丙氧基)-2-甲基丙酰氯 | 5542-60-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 2-(4-氯丙氧基)-2-甲基丙酰氯
• 中文别名: 对氯苯甲氧基二甲基乙酰氯；2-(4-氯苯氧基)-2-甲基丙酰氯
• 英文名称: clofibryl chloride
• 英文别名: clofibroylchloride；2-(p-chlorophenoxy)-2-methyl propionic acid chloride；2-(4-Chlorophenoxy)-2-methylpropanoyl chloride
• CAS: 5542-60-9
• 化学式: C₁₀H₁₀Cl₂O₂
• mdl: MFCD00128244
• 分子量: 233.094
• InChiKey: OODRWLGKUBMFLZ-UHFFFAOYSA-N

物化性质

• 沸点：
  120 °C

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 安全说明：
  S26
• 危险类别码：
  R34
• 海关编码：
  2918990090
• 危险品运输编号：
  UN 3265

SDS

Name:	2-(4-Chlorophenoxy)-2-methylpropanoyl chloride 95+% Material Safety Data Sheet
Synonym:
CAS:	5542-60-9

Section 1 - Chemical Product MSDS Name:2-(4-Chlorophenoxy)-2-methylpropanoyl chloride 95+% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
5542-60-9	2-(4-Chlorophenoxy)-2-methylpropanoyl	95+%	unlisted

Hazard Symbols: C
Risk Phrases: 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Causes burns.Moisture sensitive.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Do not induce vomiting. Get medical aid immediately.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use foam, dry chemical, or carbon dioxide.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Corrosives area. Store under an inert atmosphere.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 5542-60-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: colorless
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 120 - 122 deg C @15mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H10Cl2O2
Molecular Weight: 233

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials, exposure to moist air or water.
Incompatibilities with Other Materials:
Amines, strong oxidizing agents, bases, alcohols.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 5542-60-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-(4-Chlorophenoxy)-2-methylpropanoyl chloride - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S.*
Hazard Class: 8
UN Number: 3265
Packing Group: II
IMO
Shipping Name: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3265
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE LIQUID, ACIDIC, ORGANIC, N.O.S.
Hazard Class: 8
UN Number: 3265
Packing group: II

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 5542-60-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 5542-60-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5542-60-9 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-(4-氯丙氧基)-2-甲基丙酰氯 在 吡啶 、 乙醇 、 苯 作用下， 生成 氯贝特
  参考文献：
  名称：

  Julia, Bulletin de la Societe Chimique de France, 1956, p. 776,780, 781

  摘要：

  DOI：
• 作为产物：
  描述：

  氯贝酸 在 氯化亚砜 作用下， 生成 2-(4-氯丙氧基)-2-甲基丙酰氯
  参考文献：
  名称：

  2-甲基-2-苯氧基-丙酰基-氰基亚甲基三苯基膦的热解中的串联分子内wittig和克莱森重排反应：取代的2H-1-苯并吡喃和苯并呋喃的合成

  摘要：

  报道了在真空中2-苯甲基环中含有甲基-甲氧基和氯-取代基的2-乙基-2-苯氧基丙酰基-氰基亚甲基三苯基菲花烷及其衍生物的制备和热解。该方法将通过分子内维蒂希反应及其克莱森重排制备苯基炔丙基醚的步骤合并为一个步骤。最终产物是相应的2H-1-苯并吡喃或苯并呋喃或两者的混合物。衍生自含有2-甲基苯氧基的叶立德的炔丙基醚不仅生成4-氰基-2,2,8-三甲基-2H-1-苯并吡喃，而且生成7-氰基-6-异吡啶基亚基-1-甲基-三甲基[3.2 .1.0 2,7 ] -辛-3-烯-8-酮，为次要产物。

  DOI：

  10.1016/s0040-4020(01)87711-5

文献信息

• Identification of Anthranilic Acid Derivatives as a Novel Class of Allosteric Inhibitors of Hepatitis C NS5B Polymerase
  作者：Thomas Nittoli、Kevin Curran、Shabana Insaf、Martin DiGrandi、Mark Orlowski、Rajiv Chopra、Atul Agarwal、Anita Y. M. Howe、Amar Prashad、M. Brawner Floyd、Bernard Johnson、Alan Sutherland、Karen Wheless、Boris Feld、John O'Connell、Tarek S. Mansour、Jonathan Bloom

  DOI：10.1021/jm061428x

  日期：2007.5.1

  A series of potent anthranilic acid-based inhibitors of the hepatitis C NS5B polymerase has been identified. The inhibitors bind to a site on NS5B between the thumb and palm regions adjacent to the active site as determined by X-ray crystallography of the enzyme-inhibitor complex. Guided by both molecular modeling and traditional SAR, the enzyme activity of the initial hit was improved by approximately

  已鉴定出一系列强效邻氨基苯甲酸丙型肝炎 NS5B 聚合酶抑制剂。通过酶抑制剂复合物的 X 射线晶体学测定，抑制剂与 NS5B 上拇指和手掌区域之间与活性位点相邻的位点结合。在分子建模和传统 SAR 的指导下，初始命中的酶活性提高了约 100 倍，产生了一系列有效且选择性的 NS5B 抑制剂，IC50 值低至 10 nM。这些化合物也是培养的 HUH7 细胞中 HCV 复制子的抑制剂。
• Discovery of AdipoRon analogues as novel AMPK activators without inhibiting mitochondrial complex I
  作者：Geng Sun、Yanping You、Haobin Li、Yalong Cheng、Ming Qian、Xinyu Zhou、Haoliang Yuan、Qing-Long Xu、Liang Dai、Pengfei Wang、Keguang Cheng、Xiaoan Wen、Caiping Chen

  DOI：10.1016/j.ejmech.2020.112466

  日期：2020.8

  inhibition of mitochondrial complex I, leading to increased risk of lactic acidosis. In order to find novel AdipoRon analogues that activate AMPK without inhibition of complex I, 27 analogues of AdipoRon were designed, synthesized and biologically evaluated. As results, benzyloxy arylamide B10 was identified as a potent AMPK activator without inhibition of complex I. B10 dose-dependently improved glucose

  AMPK的激活成为代谢疾病的潜在治疗方法。据称AdipoRon是一种脂联素受体激动剂，可通过脂联素受体1（AdipoR1）激活AMPK。但是，AdipoRon还显示出对线粒体复合体I的中等抑制作用，导致乳酸性酸中毒的风险增加。为了找到激活AMPK而不抑制复合物I的新型AdipoRon类似物，设计，合成和生物学评估了27种AdipoRon类似物。结果，苄氧基芳基酰胺B10被确定为有效的AMPK活化剂，而没有抑制复合物I。B10剂量依赖性地改善了正常小鼠的葡萄糖耐量，并显着降低了db / db糖尿病小鼠的空腹血糖水平并改善了其胰岛素抵抗。更重要的是，与泛AMPK激活剂MK-8722不同，B10不会引起心脏肥大，可能是由于其在肌肉组织而非心脏组织中选择性激活了AMPK。在一起，B10代表一类新的AMPK激活剂，具有抗代谢疾病的潜在治疗潜力。
• N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
  申请人：HUTCHINSON John Howard

  公开号：US20090197959A1

  公开（公告）日：2009-08-06

  Described herein are compounds that are antagonists of PGD 2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD 2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD 2 -dependent or PGD 2 -mediated conditions or diseases.

  本发明描述了PGD2受体的拮抗剂化合物。同时，还描述了包含本发明所述化合物的药物组合物，以及使用这些PGD2受体拮抗剂的方法，单独使用或与其他化合物联合使用，用于治疗呼吸系统、心血管系统以及其它依赖或由PGD2介导的条件或疾病。
• 一类PPAR蛋白激活剂的双酯类化合物
  申请人：南昌弘益科技有限公司

  公开号：CN112028773B

  公开（公告）日：2023-08-04

  本发明涉及一类PPAR蛋白激活剂的双酯类化合物。该化合物为式(I)化合物及其药学上可接受的盐、前药和溶剂合物，及包含所述化合物的药物组合物，并涉及其合成方法。此外，本发明涉及包含所述化合物的药物组合物，可用于预防或治疗与PPPAR蛋白相关疾病的PPAR蛋白激活剂。
• Synthesis and antitumor properties of N1-acyloxymethyl derivatives of bis(2,6-dioxopiperazines).
  作者：Jun Chao CAI、Han Li SHU、Cai Fang TANG、Toshihiko KOMATSU、Toshiyuki MATSUNO、Toshiharu NARITA、Shin-ichi YAGUCHI、Yuji KOIDE、Muneaki TAKASE

  DOI：10.1248/cpb.37.2976

  日期：——

  Many N1-acyloxymethyl derivatives VI of bis(2, 6-dioxopiperazine) I, ICRF-154, were prepared and tested for antitumor activity. The treatment of I with formaldehyde gave a crystalline bis(N1-hydroxymethyl) derivative VII, which was acylated under various conditions to give bis(N1-acyloxymethyl) derivatives VI. Antitumor activity of VI against P388 leukemia in mice was studied.Several bis(N1-acyloxymethyl)compounds such as phenylacetyloxymethyl VI-6, methoxycarbonyloxymethyl VI-41, isobutoxycarbonyloxymethyl VI-44, and furancarboxymethyl VI-38 compounds were found to have potent antitumor activities. On the other hand, water-soluble esters having an amine or a carboxylic acid function in their acyl groups showed rather reduced activity.These bis(N-1-acyloxymethyl) derivatives VI were presumably hydrolyzed into the parent bis(2, 6-dioxopiperazine) I by nonspecific esterase in the body to exhibit their antitumor activity.

  许多双(2,6-二氧哌嗪)I、ICRF-154的N1-酰氧甲基衍生物VI被制备并测试了其抗肿瘤活性。将I与甲醛反应得到结晶的双(N1-羟甲基)衍生物VII，该衍生物在不同条件下酰化得到双(N1-酰氧甲基)衍生物VI。研究了VI对小鼠P388白血病的抗肿瘤活性。发现几种双(N1-酰氧甲基)化合物如苯乙酰氧甲基VI-6、甲氧羰基氧甲基VI-41、异丁氧羰基氧甲基VI-44和呋喃甲酰甲基VI-38具有强大的抗肿瘤活性。另一方面，酰基中含有氨基或羧酸功能的水溶性酯类显示出较低的活性。这些双(N-1-酰氧甲基)衍生物VI可能通过体内非特异性酯酶水解为母体双(2,6-二氧哌嗪)I来展现其抗肿瘤活性。